Back to top

moving-average-crossover: Archive

Zacks Equity Research

Teradata (TDC) Surges 5.0%: Is This an Indication of Further Gains?

Teradata (TDC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

TDCPositive Net Change WDCNegative Net Change

Zacks Equity Research

Aquestive Therapeutics (AQST) Moves 6.6% Higher: Will This Strength Last?

Aquestive Therapeutics (AQST) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

AQSTNegative Net Change ARDXNegative Net Change

Zacks Equity Research

Edgewell Personal (EPC) Surges 15.4%: Is This an Indication of Further Gains?

Edgewell Personal (EPC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

EPCPositive Net Change CHDPositive Net Change

Zacks Equity Research

Varonis (VRNS) Soars 7.1%: Is Further Upside Left in the Stock?

Varonis (VRNS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

VRNSPositive Net Change CHKPPositive Net Change

Zacks Equity Research

Global Partners (GLP) Surges 6.9%: Is This an Indication of Further Gains?

Global Partners (GLP) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

GLPPositive Net Change CAPLNegative Net Change

Zacks Equity Research

Kymera Therapeutics (KYMR) Soars 10.0%: Is Further Upside Left in the Stock?

Kymera Therapeutics (KYMR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

KYMRPositive Net Change INSMNegative Net Change

Zacks Equity Research

Strength Seen in 4D Molecular Therapeutics (FDMT): Can Its 7.9% Jump Turn into More Strength?

4D Molecular Therapeutics (FDMT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

FDMTNegative Net Change ZTSPositive Net Change

Zacks Equity Research

Semtech (SMTC) Just Overtook the 20-Day Moving Average

Should investors be excited or worried when a stock crosses above the 20-day simple moving average?

SMTCNegative Net Change

Zacks Equity Research

Qorvo (QRVO) Surges 3.6%: Is This an Indication of Further Gains?

Qorvo (QRVO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

QRVONegative Net Change SWKSNegative Net Change

Zacks Equity Research

Visteon (VC) Surges 5.4%: Is This an Indication of Further Gains?

Visteon (VC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

VCPositive Net Change HYLNNegative Net Change